Johnson & Johnson
NYSE: JNJ
$152.97
-$1.80 (-1.2%)
Closing Price on November 19, 2024
JNJ Articles
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had enjoyed an incredible...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. According to Reuters, OPEC will probably keep oil output...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Abbott Labs (ABT) which just launched a new stent...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Abbot Labs (ABT) is trying to get into the stent...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Several studies which showed that stents could cause...
Published:
According to Reuters, BHP Billiton (BHP) will not sell its petroleum division, as had been rumored, to finance a bid for Rio Tinto (RTP). Reuters writes that most of the Hershey (HSY) was pushed out...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The markets haven’t fallen apart after yesterday’s...
Published:
Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson. It now has long-term debt of almost $8.3 billion. Troubles in its...
Published:
With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks listing lower after the Exxon miss, we wanted to show a brief comparison of...
Published:
Last Updated:
"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up in South Florida. Still, restoring luster to the...
Published:
Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the company itself. Luckily for Amgen, much of the bad news may already be baked...
Published:
Last Updated:
Johnson & Johnson (JNJ) announced third-quarter sales of $15.0 billion, an increase of 12.7% as compared to the third quarter of 2006.Net earnings and diluted earnings per share for the third...
Published:
Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns about whether the product has long-term risks or whether it is more effective...
Published:
Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It is a perverse selection because Boston Scientific (BSX) and Johnson & Johnson...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Stent sales for Boston Scientific (BSX) and Johnson...
Published: